MicroRNA-374 Exerts Protective Effects by Inhibiting SP1 Through Activating the PI3K/Akt Pathway in Rat Models of Myocardial Ischemia-Reperfusion After Sevoflurane Preconditioning.
Zhang, Shu-Bo
MicroRNA-374 Exerts Protective Effects by Inhibiting SP1 Through Activating the PI3K/Akt Pathway in Rat Models of Myocardial Ischemia-Reperfusion After Sevoflurane Preconditioning. [electronic resource] - Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2018 - 1455-1470 p. digital
Publication Type: Journal Article; Retracted Publication
1421-9778
10.1159/000489186 doi
3' Untranslated Regions
Animals
Antagomirs--metabolism
Base Sequence
Creatine Kinase--blood
Disease Models, Animal
Down-Regulation--drug effects
G1 Phase Cell Cycle Checkpoints
Glycogen Synthase Kinase 3 beta--metabolism
Heme Oxygenase-1--metabolism
Interleukin-6--metabolism
Ischemic Postconditioning
Male
Malondialdehyde--blood
Methyl Ethers--pharmacology
MicroRNAs--antagonists & inhibitors
Myocardial Reperfusion Injury--pathology
Nitric Oxide Synthase Type II--metabolism
Phosphatidylinositol 3-Kinases--metabolism
Proto-Oncogene Proteins c-akt--metabolism
Proto-Oncogene Proteins c-fos--metabolism
RNA Interference
RNA, Small Interfering--metabolism
Rats
Rats, Sprague-Dawley
Sequence Alignment
Sevoflurane
Signal Transduction--drug effects
Sp1 Transcription Factor--antagonists & inhibitors
Superoxide Dismutase--blood
Tumor Necrosis Factor-alpha--metabolism
Tumor Suppressor Protein p53--metabolism
Up-Regulation--drug effects
MicroRNA-374 Exerts Protective Effects by Inhibiting SP1 Through Activating the PI3K/Akt Pathway in Rat Models of Myocardial Ischemia-Reperfusion After Sevoflurane Preconditioning. [electronic resource] - Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2018 - 1455-1470 p. digital
Publication Type: Journal Article; Retracted Publication
1421-9778
10.1159/000489186 doi
3' Untranslated Regions
Animals
Antagomirs--metabolism
Base Sequence
Creatine Kinase--blood
Disease Models, Animal
Down-Regulation--drug effects
G1 Phase Cell Cycle Checkpoints
Glycogen Synthase Kinase 3 beta--metabolism
Heme Oxygenase-1--metabolism
Interleukin-6--metabolism
Ischemic Postconditioning
Male
Malondialdehyde--blood
Methyl Ethers--pharmacology
MicroRNAs--antagonists & inhibitors
Myocardial Reperfusion Injury--pathology
Nitric Oxide Synthase Type II--metabolism
Phosphatidylinositol 3-Kinases--metabolism
Proto-Oncogene Proteins c-akt--metabolism
Proto-Oncogene Proteins c-fos--metabolism
RNA Interference
RNA, Small Interfering--metabolism
Rats
Rats, Sprague-Dawley
Sequence Alignment
Sevoflurane
Signal Transduction--drug effects
Sp1 Transcription Factor--antagonists & inhibitors
Superoxide Dismutase--blood
Tumor Necrosis Factor-alpha--metabolism
Tumor Suppressor Protein p53--metabolism
Up-Regulation--drug effects